You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

Details for Patent: 9,622,994


✉ Email this page to a colleague

« Back to Dashboard


Title:Method for the treatment of acne using pharmaceutical compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid
Abstract: Dermatological disorders having an inflammatory or proliferative component, notably common acne, are treated with topically applicable pharmaceutical compositions containing about 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid (adapalene) or salt thereof, formulated into pharmaceutically acceptable media therefor, advantageously formulated into topically applicable gels, preferably aqueous gels, creams, lotions or solutions.
Inventor(s): Graeber; Michael (Lawrenceville, NJ), Czernielewski; Janusz (Biot, FR)
Assignee: GALDERMA RESEARCH & DEVELOPMENT (Biot, FR)
Filing Date:Oct 27, 2014
Application Number:14/524,602
Claims:1. A method for treating common acne, comedones, polymorphous acne, nodulocystic acne, acne conglobata, or secondary acne afflicting the skin of an individual in need of such treatment, comprising topically administering to said individual a topically applicable pharmaceutical aqueous gel composition consisting essentially of an anti-acne effective amount of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid (adapalene) of 0.3% by weight thereof, formulated into a topically applicable, pharmaceutically acceptable aqueous gel medium therefor, wherein said aqueous gel medium comprises at least one ingredient selected from the group consisting of carbomers, polymeric emulsifying agents, polysaccharidic biopolymers, gums, alginates, modified celluloses, starch derived products, a mix of polysorbate 80 and isohexadecane and acrylamide/sodium acryloyldimethyltaurate, and mixtures thereof.

2. The method as defined by claim 1, said aqueous gel medium comprising at least one carbomer.

3. The method as defined by claim 1, said aqueous gel medium comprising at least one polymeric emulsifying agent.

4. The method as defined by claim 1, said aqueous gel medium comprising at least one polysaccharidic biopolymer.

5. The method as defined by claim 1, said aqueous gel medium comprising at least one gum.

6. The method as defined by claim 1, said aqueous gel medium comprising at least one alginate.

7. The method as defined by claim 1, said aqueous gel medium comprising at least one modified cellulose.

8. The method as defined by claim 1, said aqueous gel medium comprising at least one starch derived product.

9. The method as defined by claim 1, said aqueous gelling medium comprising a mix of polysorbate 80 and isohexadecane and acrylamide/sodium acryloyldimethyltaurate.

10. The method as defined by claim 1, wherein said aqueous gel medium comprises: Carbomer, Disodium edetate, Methyl paraben, Poloxamer 124, Propylene glycol, Sodium hydroxide, and Purified water.

11. The method as defined by claim 1, wherein said aqueous gel medium comprises: Xanthan gum, Hydroxypropylethylcellulose, Disodium edetate, Methyl paraben, Phenoxyethanol, Poloxamer 124, Propylene glycol, and Purified water.

12. A method for treating common acne, comedones, polymorphous acne, nodulocystic acne, acne conglobata, or secondary acne afflicting the skin of an individual in need of such treatment, comprising topically administering to said individual a topically applicable pharmaceutical aqueous cream gel composition consisting essentially of an anti-acne effective amount of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid (adapalene) of 0.3% by weight thereof, formulated into a topically applicable, pharmaceutically acceptable aqueous cream gel medium therefor.

13. The method as defined by claim 12, said aqueous cream gel medium comprising Simulgel 600 PHA (mix of polysorbate 80 and isohexadecane and acrylamide/sodium acryloyldimethyltaurate).

14. The method as defined by claim 12, said aqueous cream gel medium comprising a polymeric emulsifying agent.

15. The method as defined by claim 14, wherein said polymeric emulsifying agent is a PEMULEN (crosspolymer of acrylic acid with C10-C30 alkyl alkylates).

16. The method as defined by claim 12, wherein said aqueous cream gel medium comprises: Simulgel 600 PHA, Cetearyl isononanoate, Disodium edetate, Methyl paraben, Poloxamer 124, Propylene glycol, and Purified water.

17. The method as defined by claim 12, wherein said aqueous cream gel medium comprises: Pemulen TR1, Mineral Oil, Disodium edetate, Methyl paraben, Propyl paraben, Poloxamer 124, Propylene glycol, Sodium hydroxide: amount required to obtain a pH 5.0+/-0.3, and Purified water.

18. A method for treating common acne, comedones, polymorphous acne, nodulocystic acne, acne conglobata, or secondary acne afflicting the skin of an individual in need of such treatment, comprising topically administering to said individual a topically applicable pharmaceutical cream composition consisting essentially of an anti-acne effective amount of 6-[3-(1-adamantyl)-4-methoxyphenylj-2-naphthoic acid (adapalene) of 0.3% by weight thereof, formulated into a topically applicable, pharmaceutically acceptable cream medium therefor.

19. The method as defined by claim 18, wherein said cream medium comprises at least one ingredient selected from the group consisting of silicone oils, siliconed oily substances, siliconed fatty substances, non-siliconed fatty substances, vegetable oils, mineral oils, animal oils and synthetic oils, and mixtures thereof.

20. The method as defined by claim 19, wherein said cream medium comprises at least one ingredient selected from the group consisting of perhydrosqualene, cyclomethicone, PEG-20 methyl glucose sequistearate, methyl glucose sequistearate, and mixtures thereof.

21. The method as defined by claim 18, wherein said cream medium comprises: Carbomer 934 (BF Goodrich Carbopol 974), Disodium edetate, PEG 20 methyl glucose sesquistearate, Methyl glucose sesquistearate Glycerol, Methyl paraben, Cyclomethicone, Perhydrosqualene, Phenoxyethanol, Propyl paraben, Sodium hydroxide quantity required for pH 6.5+/-0.3, and Purified water.

22. A method for treating common acne, comedones, polymorphous acne, nodulocystic acne, acne conglobata, or secondary acne afflicting the skin of an individual in need of such treatment, comprising topically administering to said individual a topically applicable pharmaceutical aqueous lotion composition consisting essentially of an anti-acne effective amount of 6-[3-(1-adamantyl)-4-methoxypheny11-2-naphthoic acid (adapalene) of 0.3% by weight thereof, formulated into a topically applicable, pharmaceutically acceptable aqueous lotion medium therefor.

23. The method as defined by claim 22, wherein said aqueous lotion medium comprises at least one ingredient selected from the group consisting of humectant agent, pro-penetrant agent, propylene glycol, PEG400, mineral oils, lipophilic substances, caprylic/capric triglycerides, emulsifying agent, and mixtures thereof.

24. The method as defined by claim 22, wherein said aqueous lotion medium comprises at least one ingredient selected from the group consisting of propylene glycol, glycerine, sorbitol, polyethylene glycol, mineral oils, perhydrosqualene, caprylic/capric triglycerides, PEG-20 methyl glucose sequistearate, methyl glucose sequistearate, and mixtures thereof.

25. The method as defined by claim 22, wherein said aqueous lotion medium comprises: Methyl paraben, Simulgel 600 PHA, Steareth 21, Glyceryl and PEG 100 stearate, Disodium edetate, Propyl paraben, Perhydrosqualene, Cetearyl isononanoate, Sodium Hydroxide 10% m/m, and Purified water.

26. The method as defined by claim 22, wherein said aqueous lotion medium comprises: Disodium EDTA, Methyl paraben, Glycerine, Carbopoi 981 NF, Propyl paraben, Ceteareth 20, Stearyl alcohol, Caprylic/capric triglycerides, Glyceryl and PEG 100 stearate, Cyclomethicone 5, Poloxamer 124, Propylene glycol, Simulgel 600 PHA, Solution aq. NaOH 10%, and Purified water.

27. The method as defined by claim 22, wherein said aqueous lotion medium comprises: EDTA disodium, Methyl paraben, Carbopol 980 NF, Carbopol 981 NF, Glycerine, Phenoxyethanol, Propyl paraben, Methyl glucose sesquistearate, PEG 20 methyl glucose sesquistearate, Caprylic/capric triglycerides, Dimethicone 20 cst, Poloxamer 124, Propylene glycol, Sodium Hydroxide 10% m/m, and Purified water.

28. A method for treating common acne, comedones, polymorphous acne, nodulocystic acne, acne conglobata, or secondary acne afflicting the skin of an individual in need of such treatment, comprising topically administering to said individual a topically applicable pharmaceutical spray solution composition consisting essentially of an anti-acne effective amount of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid (adapalene) of 0.3% by weight thereof, formulated into a topically applicable, pharmaceutically acceptable spray solution medium therefor, said spray solution medium comprising caprylic/capric triglycerides.

29. The method as defined by claim 28, wherein said spray solution medium further comprises at least one ingredient selected from the group consisting of humectant agent, pro-penetrant agent, propylene glycol, polyethylene glycol, PEG400, a lipophilic substance, siliconed fatty substances, non-siliconed fatty substances, and mixtures thereof.

30. The method as defined by claim 28, wherein said spray solution medium comprises: caprylic/capric triglycerides, N-methyl pyrrolidone, and ethanol.

31. The method as defined by claim 1, wherein said aqueous gel medium comprises at least one inert additive selected from the group consisting of: wetting agents; flavor enhancers; preservatives; stabilizers; moisture regulators; pH regulators; osmotic pressure modifiers; emulsifiers; UV-A and UV-B screening agents; antioxidants; and combinations thereof.

32. The method as defined by claim 12, wherein said aqueous cream gel medium comprises at least one inert additive selected from the group consisting of: wetting agents; flavor enhancers; preservatives; stabilizers; moisture regulators; pH regulators; osmotic pressure modifiers; emulsifiers; UV-A and UV-B screening agents, antioxidants; and combinations thereof.

33. The method as defined by claim 18, wherein said cream medium comprises at least one inert additive selected from the group consisting of: wetting agents; flavor enhancers; preservatives; stabilizers; moisture regulators; pH regulators; osmotic pressure modifiers; emulsifiers; UV-A and UV-B screening agents; antioxidants; and combinations thereof.

34. The method as defined by claim 22, wherein said aqueous lotion medium comprises at least one inert additive selected from the group consisting of: wetting agents; flavor enhancers; preservatives; stabilizers; moisture regulators; pH regulators; osmotic pressure modifiers; emulsifiers; UV-A and UV-B screening agents; antioxidants; and combinations thereof.

35. The method as defined by claim 28, wherein said spray solution medium comprises at least one inert additive selected from the group consisting of: wetting agents; flavor enhancers; preservatives; stabilizers; moisture regulators; pH regulators; osmotic pressure modifiers; emulsifiers; UV-A and UV-B screening agents; antioxidants; and combinations thereof.

36. The method as defined by claim 2, wherein said aqueous gel medium comprises carbomer 940.

37. The method as defined by claim 3, wherein said aqueous gel medium comprises a crosspolymer of acrylic acid with C10-C30 alkyl acrylates (PEMULEN).

38. The method as defined by claim 4, wherein said aqueous gel medium comprises Xanthan gum.

39. The method as defined by claim 5, wherein said aqueous gel medium comprises caroub gum or guar gum.

40. The method as defined by claim 7, wherein said aqueous gel comprises at least one member selected from the group consisting of hydroxyethylcellulose, methylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose and carboxymethylcellulose.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.